Dale Wolf - Molina Healthcare Non-Executive Independent Director
| MOH Stock | USD 297.97 7.18 2.47% |
Director
Mr. Dale B. Wolf is Independent Chairman of the Board of Molina Healthcare, Inc. He Has served as President and Chief Executive Officer of Onecall Care Management from January 2016 to February 2019, and Executive Chairman from September 2015 to January 2016. President and CEO, DBW Healthcare, Inc. from January 2014 to June 2018. Executive Chairman, Correctional Healthcare Companies, Inc., a national provider of correctional healthcare solutions, from December 2012 to July 2014. Chief Executive Officer of Coventry Health Care, Inc. from 2005 to 2009. Executive Vice President, Chief Financial Officer, and Treasurer of Coventry Health Care, Inc. from 1996 to 2005. Member of the Board of Directors of Correctional Healthcare Companies, Inc. from December 2012 to July 2014. Member of the Board of Directors of Coventry Healthcare, Inc. from January 2005 to April 2009. Member of the Board of Directors of Catalyst Health Solutions, Inc. from 2003 to 2012. Graduated Eastern Nazarene College with a Bachelor of Arts degree in Mathematics, with honors. Completed MIT Sloan School Senior Executive Program. Fellow in the Society of Actuaries since 1979 since 2017.
| Age | 66 |
| Tenure | 7 years |
| Address | 200 Oceangate, Long Beach, CA, United States, 90802 |
| Phone | 562 435 3666 |
| Web | https://www.molinahealthcare.com |
Dale Wolf Latest Insider Activity
Tracking and analyzing the buying and selling activities of Dale Wolf against Molina Healthcare stock is an integral part of due diligence when investing in Molina Healthcare. Dale Wolf insider activity provides valuable insight into whether Molina Healthcare is net buyers or sellers over its current business cycle. Note, Molina Healthcare insiders must abide by specific rules, including filing SEC forms every time they buy or sell Molina Healthcare'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Dale Wolf over a year ago Exercise or conversion by Dale Wolf of 4572 shares of NuVasive subject to Rule 16b-3 |
Molina Healthcare Management Efficiency
The company has Return on Asset of 0.069 % which means that on every $100 spent on assets, it made $0.069 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.2645 %, implying that it generated $0.2645 on every 100 dollars invested. Molina Healthcare's management efficiency ratios could be used to measure how well Molina Healthcare manages its routine affairs as well as how well it operates its assets and liabilities. The Molina Healthcare's current Return On Capital Employed is estimated to increase to 0.43, while Return On Tangible Assets are projected to decrease to 0.07. As of now, Molina Healthcare's Other Current Assets are increasing as compared to previous years. The Molina Healthcare's current Non Current Assets Total is estimated to increase to about 2.5 B, while Intangible Assets are projected to decrease to under 120.3 M.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| George Kurian | Cigna Corp | 54 | |
| Robert Ditmore | Centene Corp | 86 | |
| Eric Foss | Cigna Corp | 62 | |
| William Trubeck | Centene Corp | 74 | |
| James OBrien | Humana Inc | 66 | |
| David Jones | Humana Inc | 71 | |
| William Weldon | CVS Health Corp | 72 | |
| Richard Gephardt | Centene Corp | 79 | |
| Valerie Rice | UnitedHealth Group Incorporated | 58 | |
| Donna Zarcone | Cigna Corp | 63 | |
| Marissa Peterson | Humana Inc | 58 | |
| Karen Katz | Humana Inc | 64 | |
| Frank DAmelio | Humana Inc | 63 | |
| Lori Robinson | Centene Corp | 62 | |
| Frank Bisignano | Humana Inc | 62 | |
| Roman Martinez | Cigna Corp | 71 | |
| Eric Wiseman | Cigna Corp | 65 | |
| Glenn Renwick | UnitedHealth Group Incorporated | 64 | |
| JeanPierre Millon | CVS Health Corp | 70 | |
| Frederick Eppinger | Centene Corp | 62 | |
| Alecia DeCoudreaux | CVS Health Corp | 66 | |
Management Performance
| Return On Equity | 0.26 | ||||
| Return On Asset | 0.069 |
Molina Healthcare Leadership Team
Elected by the shareholders, the Molina Healthcare's board of directors comprises two types of representatives: Molina Healthcare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Molina. The board's role is to monitor Molina Healthcare's management team and ensure that shareholders' interests are well served. Molina Healthcare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Molina Healthcare's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Joseph CFA, Senior Relations | ||
| Jason Dees, Executive Vice President - Marketplace | ||
| James Woys, Executive Vice President - Health Plan Services | ||
| Maurice CPA, Chief Officer | ||
| Garrey Carruthers, Independent Director | ||
| Brian Maddy, President - Oklahoma | ||
| FAAFP DO, Executive Officer | ||
| Joseph Zubretsky, President, Chief Executive Officer, Director | ||
| David Reynolds, Senior Plans | ||
| Esq JD, Chief Sec | ||
| Thomas Tran, Chief Financial Officer, Treasurer | ||
| John Kotal, Chief California | ||
| Richard Zoretic, Independent Director | ||
| Dale Wolf, Non-Executive Independent Director | ||
| Maurice Hebert, Chief Accounting Officer | ||
| Mark Keim, Executive Vice President - Executive Vice President Strategic Planning, Corporate Development & Transformation | ||
| Jeffrey Geyer, Head Relations | ||
| Stephen Lockhart, Independent Director | ||
| Barbara Brasier, Independent Director | ||
| Richard Schapiro, Independent Director | ||
| Jeff Barlow, Senior Vice President General Counsel, Secretary | ||
| Joann ZarzaGarrido, Vice Compliance | ||
| Dave Reynolds, Senior Vice President - Health Plans | ||
| Keith Wilson, Chief Officer | ||
| Daniel Cooperman, Non-Executive Independent Director | ||
| Ronna Romney, Independent Vice Chairman of the Board | ||
| Larry Anderson, Executive Officer | ||
| David Pollack, VP Operations | ||
| Marc Russo, Executive Vice President - Medicaid Health Plans | ||
| Keith MD, Chief Officer | ||
| Steven Orlando, Independent Director |
Molina Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Molina Healthcare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.26 | ||||
| Return On Asset | 0.069 | ||||
| Profit Margin | 0.03 % | ||||
| Operating Margin | 0.05 % | ||||
| Current Valuation | 9.95 B | ||||
| Shares Outstanding | 57.2 M | ||||
| Shares Owned By Insiders | 1.13 % | ||||
| Shares Owned By Institutions | 99.91 % | ||||
| Number Of Shares Shorted | 888.43 K | ||||
| Price To Earning | 26.49 X |
Currently Active Assets on Macroaxis
When determining whether Molina Healthcare offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Molina Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Molina Healthcare Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Molina Healthcare Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Molina Healthcare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For more detail on how to invest in Molina Stock please use our How to Invest in Molina Healthcare guide.You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Molina Healthcare. If investors know Molina will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Molina Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.342 | Earnings Share 19.66 | Revenue Per Share 649.831 | Quarterly Revenue Growth 0.174 | Return On Assets 0.069 |
The market value of Molina Healthcare is measured differently than its book value, which is the value of Molina that is recorded on the company's balance sheet. Investors also form their own opinion of Molina Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Molina Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Molina Healthcare's market value can be influenced by many factors that don't directly affect Molina Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Molina Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Molina Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Molina Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.